CD8+ T-cell–Mediated Immunoediting Influences Genomic Evolution and Immune Evasion in Murine Gliomas
Open Access
- 19 May 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 26 (16), 4390-4401
- https://doi.org/10.1158/1078-0432.ccr-19-3104
Abstract
Cancer immunoediting shapes tumor progression by the selection of tumor cell variants that can evade immune recognition. Given the immune evasion and intratumor heterogeneity characteristic of gliomas, we hypothesized that CD8+ T cells mediate immunoediting in these tumors. We developed retrovirus-induced PDGF+Pten−/− murine gliomas and evaluated glioma progression and tumor immunogenicity in the absence of CD8+ T cells by depleting this immune cell population. Furthermore, we characterized the genomic alterations present in gliomas that developed in the presence and absence of CD8+ T cells. Upon transplantation, gliomas that developed in the absence of CD8+ T cells engrafted poorly in recipients with intact immunity but engrafted well in those with CD8+ T-cell depletion. In contrast, gliomas that developed under pressure from CD8+ T cells were able to fully engraft in both CD8+ T-cell–depleted mice and immunocompetent mice. Remarkably, gliomas developed in the absence of CD8+ T cells exhibited increased aneuploidy, MAPK pathway signaling, gene fusions, and macrophage/microglial infiltration, and showed a proinflammatory phenotype. MAPK activation correlated with macrophage/microglia recruitment in this model and in the human disease. Our studies indicate that, in these tumor models, CD8+ T cells influence glioma oncogenic pathways, tumor genotype, and immunogenicity. This suggests immunoediting of immunogenic tumor clones through their negative selection by CD8+ T cells during glioma formation.Keywords
Other Versions
Funding Information
- HHS | NIH | National Institute of Neurological Disorders and Stroke (1R01NS110703-01A1)
- HHS | National Institutes of Health (5DP5OD021356-05)
- HHS | NIH | National Cancer Institute (P50CA221747)
- NU | Robert H. Lurie Comprehensive Cancer Center (P30CA060553)
- Matthew Larson Foundation for Pediatric Brain Tumors
This publication has 47 references indexed in Scilit:
- Mitogen-activated protein kinases in innate immunityNature Reviews Immunology, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling PathwayScience Signaling, 2012
- Glioblastoma Models Reveal the Connection between Adult Glial Progenitors and the Proneural PhenotypePLOS ONE, 2011
- Intratumoral Mediated Immunosuppression is Prognostic in Genetically Engineered Murine Models of Glioma and Correlates to Immunotherapeutic ResponsesClinical Cancer Research, 2010
- Adaptive immunity maintains occult cancer in an equilibrium stateNature, 2007
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells.The Journal of Experimental Medicine, 1982
- Cellular and Humoral immunity to Different Types of Human NeoplasmsNature, 1968